[1]
S. Nandi and M. C. Bagchi, “Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer”, J. Can. Res. Updates, vol. 11, pp. 63–69, Oct. 2022.